201 related articles for article (PubMed ID: 36217461)
1. Leucine zipper protein 2 serves as a prognostic biomarker for prostate cancer correlating with immune infiltration and epigenetic regulation.
Feng D; Zhu W; Shi X; Wei W; Han P; Wei Q; Yang L
Heliyon; 2022 Oct; 8(10):e10750. PubMed ID: 36217461
[TBL] [Abstract][Full Text] [Related]
2. Identification of senescence-related molecular subtypes and key genes for prostate cancer.
Feng DC; Zhu WZ; Shi X; Xiong Q; You J; Wei Q; Yang L
Asian J Androl; 2023; 25(2):223-229. PubMed ID: 36124532
[TBL] [Abstract][Full Text] [Related]
3. A pan-cancer analysis of the oncogenic role of leucine zipper protein 2 in human cancer.
Feng D; Shi X; Zhu W; Zhang F; Li D; Han P; Wei Q; Yang L
Exp Hematol Oncol; 2022 Sep; 11(1):55. PubMed ID: 36109820
[TBL] [Abstract][Full Text] [Related]
4. Downregulation of LUZP2 Is Correlated with Poor Prognosis of Low-Grade Glioma.
Li Y; Deng G; Qi Y; Zhang H; Jiang H; Geng R; Ye Z; Liu B; Chen Q
Biomed Res Int; 2020; 2020():9716720. PubMed ID: 32695826
[TBL] [Abstract][Full Text] [Related]
5. Mitochondria Dysfunction-Mediated Molecular Subtypes and Gene Prognostic Index for Prostate Cancer Patients Undergoing Radical Prostatectomy or Radiotherapy.
Feng D; Shi X; Zhang F; Xiong Q; Wei Q; Yang L
Front Oncol; 2022; 12():858479. PubMed ID: 35463369
[TBL] [Abstract][Full Text] [Related]
6. Energy Metabolism-Related Gene Prognostic Index Predicts Biochemical Recurrence for Patients With Prostate Cancer Undergoing Radical Prostatectomy.
Feng D; Shi X; Zhang F; Xiong Q; Wei Q; Yang L
Front Immunol; 2022; 13():839362. PubMed ID: 35280985
[TBL] [Abstract][Full Text] [Related]
7. A cellular senescence-related gene prognostic index for biochemical recurrence and drug resistance in patients with prostate cancer.
Feng D; Shi X; You J; Xiong Q; Zhu W; Wei Q; Yang L
Am J Cancer Res; 2022; 12(8):3811-3828. PubMed ID: 36119834
[TBL] [Abstract][Full Text] [Related]
8. SNAP25 is a potential prognostic biomarker for prostate cancer.
Di L; Gu M; Wu Y; Liu G; Zhang L; Li Y; Zhang W
Cancer Cell Int; 2022 Apr; 22(1):144. PubMed ID: 35392903
[TBL] [Abstract][Full Text] [Related]
9. UBASH3B Is a Novel Prognostic Biomarker and Correlated With Immune Infiltrates in Prostate Cancer.
Wang Z; Wang Y; Peng M; Yi L
Front Oncol; 2019; 9():1517. PubMed ID: 32010618
[No Abstract] [Full Text] [Related]
10. Identification of ISG15 and ZFP36 as novel hypoxia- and immune-related gene signatures contributing to a new perspective for the treatment of prostate cancer by bioinformatics and experimental verification.
Lyu F; Li Y; Yan Z; He Q; Cheng L; Zhang P; Liu B; Liu C; Song Y; Xing Y
J Transl Med; 2022 May; 20(1):202. PubMed ID: 35538543
[TBL] [Abstract][Full Text] [Related]
11. A Ferroptosis-Related Gene Prognostic Index Associated With Biochemical Recurrence and Radiation Resistance for Patients With Prostate Cancer Undergoing Radical Radiotherapy.
Feng D; Shi X; Xiong Q; Zhang F; Li D; Wei W; Yang L
Front Cell Dev Biol; 2022; 10():803766. PubMed ID: 35223835
[No Abstract] [Full Text] [Related]
12. Solute carrier family 16 member 5 downregulation and its methylation might serve as a prognostic indicator of prostate cancer.
Meng X; Yuan H; Li W; Xiong Z; Dong W; Xiao W; Zhang X
IUBMB Life; 2021 Nov; 73(11):1363-1377. PubMed ID: 34549875
[TBL] [Abstract][Full Text] [Related]
13. NEFM DNA methylation correlates with immune infiltration and survival in breast cancer.
Li D; Zhao W; Zhang X; Lv H; Li C; Sun L
Clin Epigenetics; 2021 May; 13(1):112. PubMed ID: 34001208
[TBL] [Abstract][Full Text] [Related]
14. Identification of senescence-related lncRNA prognostic index correlating with prognosis and radiosensitivity in prostate cancer patients.
Feng D; Li L; Shi X; Zhu W; Wang J; Wu R; Li D; Wei W; Han P
Aging (Albany NY); 2023 Sep; 15(18):9358-9376. PubMed ID: 37742230
[TBL] [Abstract][Full Text] [Related]
15. Comprehensive Analysis of m5C Methylation Regulatory Genes and Tumor Microenvironment in Prostate Cancer.
Yu G; Bao J; Zhan M; Wang J; Li X; Gu X; Song S; Yang Q; Liu Y; Wang Z; Xu B
Front Immunol; 2022; 13():914577. PubMed ID: 35757739
[TBL] [Abstract][Full Text] [Related]
16. Leucine Zipper-EF-Hand Containing Transmembrane Protein 1 Is a Potential Prognostic Biomarker and Promotes Cell Progression in Prostate Cancer.
Piao L; Li H; Feng Y; Li X; Cui Y; Xuan Y
Cancer Manag Res; 2020; 12():1649-1660. PubMed ID: 32184668
[TBL] [Abstract][Full Text] [Related]
17. Prognostic Value of Genes and Immune Infiltration in Prostate Tumor Microenvironment.
Sun W; Shi H; Yuan Z; Xia L; Xiang X; Quan X; Shi W; Jiang L
Front Oncol; 2020; 10():584055. PubMed ID: 33194726
[TBL] [Abstract][Full Text] [Related]
18. Immune-Related Genes Are Prognostic Markers for Prostate Cancer Recurrence.
Fu M; Wang Q; Wang H; Dai Y; Wang J; Kang W; Cui Z; Jin X
Front Genet; 2021; 12():639642. PubMed ID: 34490029
[TBL] [Abstract][Full Text] [Related]
19. A novel gene signature to predict immune infiltration and outcome in patients with prostate cancer.
Shao N; Tang H; Mi Y; Zhu Y; Wan F; Ye D
Oncoimmunology; 2020 Jun; 9(1):1762473. PubMed ID: 32923125
[TBL] [Abstract][Full Text] [Related]
20. Cloning, functional study and comparative mapping of Luzp2 to mouse chromosome 7 and human chromosome 11p13-11p14.
Wu M; Michaud EJ; Johnson DK
Mamm Genome; 2003 May; 14(5):323-34. PubMed ID: 12856284
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]